Industry Briefs: September 10, 2012
A roundup of additional company and people news from pharmaceutical and biopharmaceutical companies, their suppliers, and contract-service providers.
Company News
Boehringer Ingelheim has implemented a a flexible set-up and operational approach for disposable technologies within its biopharmaceutical development and manufacturing network. Read More
CSL Biotherapies has been awarded a contract by the US Department of Health and Human Services to supply prepandemic and pandemic vaccine antigens and related services to the US national stockpile. Read More
ICON has expanded its US and United Kingdom bioanalytical facilities to supply biomarker and cell-based assay services. Read More
MedImmune and WuXi AppTec have formed a joint venture to develop and commercialize MEDI5117, a novel biologic for autoimmune and inflammatory diseases, in China. Read More
Patheon has sold its global secondary clinical packaging and clinical distribution services business to Bellwyck Packaging Solutions, a priovider of clinical-trial and contract services for secondary packaging. Read More
FDA has approved Pfizer’s Bosulif (bosutinib), new molecular entity for treating chronic myelogenous leukemia. Read More
Sigma-Aldrich and AB SCIEX, a manufacturer of mass spectrometry instruments, have agreed to globally distribute AB SCIEX’s mass spectrometry-based tagging chemistries, called SCIEX iChemistry Solutions, for applications in basic research and applied markets. Read More
People Notes
Aceto has announced that Albert Eilender will step down from his position as CEO, effective Jan. 2, 2013. He will remain as chairman of the board of directors. Salvatore Guccione has been elected to succeed Eilender as CEO, also effective Jan. 2, 2013. Read More
AMRI has appointed Daniel Conlon as senior director of business development. Read More
SciClone Pharmaceuticals has announced announced that Mark Lotter will resign from the position of CEO of the company’s China operations division at the end of 2012. A replacement candidate has not been announced. Read More
Drug Solutions Podcast: Novel Drug Delivery Approaches: Refining AAV Vector Deliveries
May 30th 2025In this podcast episode, we discuss novel approaches to drug delivery, specifically regarding adeno-associated virus (AAV) vectors, as viewed by two industry experts who recently exhibited at the annual ASGCT meeting.
Transformations in Drug Development for Cell and Gene Therapies
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
